Treatment of Pinguecula with Eye Drops of Dobesilate
Journal of Clinical Medical Research · 19.04.2026 · 7 (1) · 1-3
DOI: 10.46889/jcmr.2026.7119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medical Research, online erschienen am 19.04.2026. Verfasst von Pedro Cuevas und 2 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Inhibition of fibroblast growth factor and vascular endothelial growth factor signalling pathways is effective in causing vessels regression in pinguecula. Regression of aberrant conjunctival vessels was documented 2 weeks after topical administration of ocular drops of dobesilate twice a day. At 2-months follow-up no recurrence nor ocular irritation were noted.
Zitieren
APA
Cuevas, P., Angulo, J., & Outeiriño, L. (2026). Treatment of Pinguecula with Eye Drops of Dobesilate. Journal of Clinical Medical Research, 7(1), 1-3. https://doi.org/10.46889/jcmr.2026.7119
Vancouver
Cuevas P, Angulo J, Outeiriño L. Treatment of Pinguecula with Eye Drops of Dobesilate. Journal of Clinical Medical Research. 2026;7(1):1-3. doi:10.46889/jcmr.2026.7119
BibTeX
@article{Cuevas2026,
author = {Cuevas, Pedro and Angulo, Javier and Outeiriño, Luis},
title = {Treatment of Pinguecula with Eye Drops of Dobesilate},
journal = {Journal of Clinical Medical Research},
year = {2026},
volume = {7},
number = {1},
pages = {1--3},
doi = {10.46889/jcmr.2026.7119}
}
EUVIMED